Pankaj Mohan
Director Ejecutivo en SONNET BIOTHERAPEUTICS HOLDINGS, INC. .
Fortuna: 110 127 $ al 30/04/2024
Cargos activos de Pankaj Mohan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Director Ejecutivo | 01/04/2020 | - |
| Presidente | 01/04/2020 | - | |
| Fundador | 01/04/2020 | - | |
| Presidente | 01/04/2020 | - | |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Presidente | 01/06/2018 | - |
| Director Ejecutivo | 01/01/2019 | - | |
| Fundador | 01/01/2015 | - | |
| Director/Miembro de la Junta | 01/01/2015 | 01/06/2018 |
Historial de carrera de Pankaj Mohan
Antiguos cargos conocidos de Pankaj Mohan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 18/06/2018 | 12/09/2019 |
| Director Ejecutivo | 01/01/2011 | 18/06/2018 | |
| Presidente | 01/01/2011 | 18/06/2018 | |
| Fundador | 05/01/2010 | 12/09/2019 | |
| Presidente | 01/01/2011 | 18/06/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2008 | 01/12/2010 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/06/2006 | 01/05/2008 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/05/1993 | 02/04/1996 |
| University College London | Corporate Officer/Principal | 01/05/1993 | 01/04/1996 |
Formación de Pankaj Mohan.
| Middlesex University Business School | Graduate Degree |
| University of Birmingham | Doctorate Degree |
| Indian Institute of Technology Roorkee | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Reino Unido | 4 |
| India | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| Chairman | 3 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| OUTLOOK THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Pankaj Mohan
- Experiencia
